Instalab

CAC Score RCA Test

Pinpoint exactly where hardened plaque is building in your heart, artery by artery.

Should you take a CAC Score RCA test?

This test is most useful if any of these apply to you.

Worried About a Family History of Heart Disease
If a parent or sibling had a heart attack early, this scan shows whether you have inherited the disease, not just the risk.
Borderline Cholesterol and Deciding on a Statin
If you are on the fence about cholesterol medication, seeing whether plaque has actually started can settle the question.
A Lifelong Endurance Athlete
Heavy training is linked to higher calcium scores. This scan tells you whether your plaque is the stable kind or worth investigating further.
Healthy but Want to Stay Ahead
Even with normal labs, this scan reveals whether atherosclerosis has started silently, before any symptom or warning sign.

About CAC Score RCA

If hardened plaque is quietly forming in the right coronary artery, you will not feel it. There are no symptoms until the vessel becomes severely narrowed or a piece of plaque ruptures and triggers a heart attack. This artery supplies the bottom and back of your heart, including the area that helps control heart rhythm.

A heart calcium scan breaks down where that plaque is building, one vessel at a time. The right coronary artery score is one piece of that picture, alongside scores for the other major heart arteries, and together they form the total calcium score that predicts your risk of a heart attack.

What This Number Actually Measures

CAC (coronary artery calcium) scoring is done with a quick, non-contrast CT scan of your chest. The scan picks up calcium deposits inside your coronary artery walls and adds them up using a method called the Agatston score. The total calcium score is the sum of four vessel-specific numbers: the left main artery, the left anterior descending artery (the one running down the front of your heart, often called the LAD), the circumflex artery (the one wrapping around the side), and the right coronary artery (the RCA, which supplies the underside and back).

Calcium in an artery is not innocent. It is a fingerprint of atherosclerosis, the slow disease in which fats, immune cells, and scar tissue build up in the artery wall and eventually harden. The presence of calcified plaque in the right coronary artery means the disease has reached a mature, fibrotic stage in that specific vessel. The amount of calcium tracks closely with how much total plaque is there, both calcified and softer non-calcified plaque mixed in.

Why The Right Coronary Artery Specifically Matters

Calcium does not deposit evenly across all four heart arteries. In a study of 1,014 adults, the LAD carried the highest average burden, with the right coronary artery the second-most affected vessel, and the circumflex the least. The mean Agatston scores were 386 for the LAD, 240 for the right coronary artery, and 176 for the circumflex. So when calcium shows up in the right coronary artery, it is part of a meaningful and common pattern of disease, not a rare or trivial finding.

Most outcome research has measured total CAC rather than each vessel individually. The vessel-specific number, including the right coronary artery score, contributes to that total but has not been as directly tied to event rates in published cohort studies. Treat the right coronary artery score as a piece of the larger calcium picture, not as a stand-alone risk number.

Heart Attack and Cardiovascular Event Risk

The total Agatston calcium score, which includes the right coronary artery contribution, is one of the strongest single predictors of future heart problems. In a meta-analysis of more than 34,000 symptomatic patients, higher total calcium scores were tied to substantially higher rates of major adverse cardiac events. In a randomized study of 1,749 people with stable chest pain, a calcium score of zero indicated a very low risk of heart attack or cardiac death, while higher scores tracked with a steadily rising risk of obstructive disease and major events at follow-up.

In younger adults, even a low amount of calcium matters. A meta-analysis in adults under roughly age 50 found that a total calcium score between 1 and 100 raised the likelihood of a cardiovascular event, and a score above 100 was tied to higher rates of both events and death. In a separate analysis of 5,115 adults aged 32 to 46 followed long-term, those with any coronary calcium had elevated risk of heart disease, cardiovascular disease, and early death, with scores of 100 or more particularly linked to early mortality.

Long-Term Mortality

Calcium scoring also predicts how long you will live, not just whether you have a heart attack. In the CAC Consortium, which followed 66,636 adults, higher total calcium scores were strongly tied to long-term, all-cause mortality and to a greater share of deaths from cardiovascular and coronary heart disease, regardless of standard risk factor burden. In a separate cohort of 23,637 adults followed for years through the Walter Reed system, the calcium score significantly improved the long-term ability to predict major adverse cardiovascular events and death even in people who looked low risk on paper.

What this means for you: the calcium score sees something a standard cholesterol panel often does not, which is whether the disease has actually started in your arteries. Two people with identical lipid numbers can have very different futures, and the calcium scan is one of the cleaner ways to tell them apart.

Reference Ranges

There is no widely accepted, vessel-specific cutpoint set for the right coronary artery score. The thresholds below come from total CAC research, where the strongest outcome data live. Treat them as orientation for total calcium burden, not as targets for any single vessel. Your right coronary artery score is one component that feeds into this total.

Total CAC Score (Agatston Units)Risk TierWhat It Suggests
0Very lowNo detectable calcified plaque. Low short and intermediate-term event risk, though softer plaque can still be present.
1 to 99MildEarly atherosclerosis is detectable. Risk is low overall but rising, especially in younger adults.
100 to 399ModerateEstablished plaque burden. Linked to meaningfully higher rates of events and early mortality.
400 or higherHighAdvanced calcified disease. Significantly elevated risk of heart attack, stroke, and death.

Because age and sex shift what is typical, many radiologists also report your percentile compared to others your age and sex. A score of 50 might be average for one person and unusually high for another. Your right coronary artery number on its own does not have published, validated risk tiers in the same way the total score does.

Tracking Your Trend

A single calcium score is a snapshot. The rate of change over time is what tells you whether your prevention strategy is working. Calcium typically grows slowly in untreated coronary disease, and progression can be measured in repeat scans years apart. Once calcium is present, it does not generally reverse, but the pace at which it grows is modifiable.

There is real measurement variability between scans, even on the same scanner. One analysis put the smallest statistically meaningful change in score at roughly 4.93 times the square root of your baseline Agatston number. That means small changes between two scans may simply be measurement noise rather than true progression.

A reasonable rhythm: get a baseline scan if you are over 40 with any cardiovascular risk factors, or earlier with strong family history. If your score is zero, repeat in 5 years. If your score is non-zero, repeat in 3 to 5 years to see your progression rate, sooner if you are starting or changing prevention therapy.

Decision Pathway for an Abnormal Result

Any non-zero calcium score, in the right coronary artery or elsewhere, is a definitive sign that atherosclerosis has started. That alone should change your prevention plan. Pair this result with ApoB (apolipoprotein B, a count of the harmful cholesterol particles in your blood), Lp(a) (lipoprotein little a, an inherited risk factor), and hs-CRP (high-sensitivity C-reactive protein, a marker of inflammation) to build a fuller risk picture.

If your total score is high or rising fast, talk to a preventive cardiologist or lipidologist. They may recommend more aggressive cholesterol lowering and consider a CT angiogram to look for soft, non-calcified plaque that calcium scoring alone cannot see. The presence of calcium in the right coronary artery specifically does not change the basic prevention plan, but it does confirm where in your heart the disease is taking hold.

When Results Can Be Misleading

A few things can throw off how to read this number:

  • Inter-scan variability: the same person scanned twice can have meaningfully different scores due to heart motion, slice thickness, and software differences. Small changes are often noise, not real progression.
  • A score of zero in younger adults: in people under 45, a zero calcium score does not reliably exclude soft, non-calcified plaque. The scan only sees calcified plaque.
  • Statin use: statins promote calcification of existing plaque as part of stabilizing it. A higher calcium score on therapy may reflect plaque becoming more stable, not more disease, which is why interpreting serial scores on statins is genuinely tricky.
  • Misclassification near the aortic root: automated scoring systems can sometimes mistake aortic calcium for right coronary artery calcium, since the right coronary artery comes off the aorta close by.

What Moves This Biomarker

Evidence-backed interventions that affect your CAC Score RCA level

Up & Down
Statin therapy
Statins are the first-line guideline therapy for lowering cardiovascular risk and they reshape coronary calcium in a counterintuitive way. They raise the calcium score by promoting calcification within existing plaque, which makes those plaques more stable and less likely to rupture, while at the same time slowing the growth of total plaque volume. In a study of 857 adults followed with serial CT angiography, statin users showed greater transformation of plaque toward dense calcium and slower overall plaque progression than non-users. A higher calcium score on statins should not be read as worsening disease.
MedicationModerate Evidence
Decrease
PCSK9 inhibitors (alirocumab or evolocumab) added to a statin
PCSK9 inhibitors are injectable cholesterol-lowering drugs that work alongside statins to drive LDL even lower. Adding them to a statin lowered the annual rate of coronary calcium progression compared with statin alone in an observational study of 151 patients. A randomized trial of alirocumab plus statin in coronary artery disease patients also showed significantly less calcification progression than statin alone over the trial period.
MedicationModerate Evidence
Decrease
Knowing your calcium score and using it to guide prevention
Simply seeing your calcium score changes behavior. A meta-analysis found that a non-zero score significantly increased the chance of starting or sticking with cholesterol-lowering medication, blood pressure treatment, aspirin, and lifestyle changes compared to standard risk assessment alone. In a randomized trial of 365 people with a family history of premature heart disease, combining a calcium score with treatment decisions reduced atherogenic cholesterol and slowed plaque progression compared with usual care.
LifestyleModerate Evidence
Increase
Very vigorous endurance exercise (high training volume in middle-aged and older athletes)
Long-time endurance athletes often have higher coronary calcium scores than less-active peers, and very vigorous exercise can accelerate calcium progression. In an observational study of 289 middle-aged and older athletes, very vigorous intensity exercise was associated with greater calcification and faster plaque growth, while merely vigorous exercise was tied to less progression. The plaque in athletes tends to be denser and more calcified, a pattern that may be more stable than the soft plaque seen in sedentary peers, which is why the clinical meaning of a high score in a lifelong athlete remains debated.
ExerciseModerate Evidence
Decrease
Vitamin K2 supplementation
Vitamin K2 helps direct calcium toward bones and away from arteries. A meta-analysis of randomized trials found that K2 supplementation slowed coronary calcium progression and lowered a marker of inactive matrix Gla protein, the protein that normally inhibits vascular calcification. A randomized trial in adults with severe coronary calcium is testing whether K2 plus vitamin D3 can slow progression in higher-risk people; an earlier trial in men without ischemic heart disease did not show a significant benefit.
SupplementModest Evidence

Frequently Asked Questions

References

22 studies
  1. Greenland P, Blaha M, Budoff M, Erbel R, Watson KJournal of the American College of Cardiology2018
  2. Lo-kioeng-shioe MS, Rijlaarsdam-hermsen D, Van Domburg RV, Hadamitzky M, Lima J, Hoeks S, Deckers JInternational Journal of Cardiology2020
  3. Biavati F, Saba L, Boussoussou M, Kofoed KF, Benedek T, Donnelly PRadiology2024
  4. Haq a, Veerati T, Walser-kuntz E, Aldujeli a, Tang M, Miedema MEuropean Journal of Preventive Cardiology2023